Go Deep
Bayer CropScience Limited
Bayer CropScience Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 23,748 | 22.6 | 5.56 | 0.03 | 3,671.80 |
| Sep 2026 | 23,748 | 22.6 | 5.56 | 0.03 | 3,671.80 |
| Sep 2026 | 23,748 | 22.5 | 5.56 | 0.03 | 3,671.80 |
| Oct 2026 | 23,688 | 21.8 | 5.39 | 0.03 | 3,554.20 |
| Oct 2026 | 22,758 | 21.4 | 5.29 | 0.03 | 3,492.00 |
Bayer CropScience Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 18,350,000,000.0 | 11,008,000,000.0 | 11,062,000,000.0 | 15,534,000,000.0 |
| Net Profit | 3,216,000,000.0 | 1,621,000,000.0 | 957,000,000.0 | 1,527,000,000.0 |
| EPS | 71.6 | 36.1 | 21.3 | 34.0 |
Bayer CropScience Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 54,980,000,000.0 | 53,141,000,000.0 | 48,921,000,000.0 | 49,449,000,000.0 | — |
| Net Profit | 6,892,000,000.0 | 5,680,000,000.0 | 7,405,000,000.0 | 7,582,000,000.0 | — |
| EPS | 153.3 | 126.4 | 164.8 | 168.7 | — |
Bayer CropScience Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 56,994,000,000.0 | 52,459,000,000.0 | 45,971,000,000.0 | 46,786,000,000.0 | — |
| Total Liabilities | 27,337,000,000.0 | 23,955,000,000.0 | 17,477,000,000.0 | 19,665,000,000.0 | — |
| Total Equity | 29,657,000,000.0 | 28,504,000,000.0 | 28,494,000,000.0 | 27,121,000,000.0 | — |
Owes vs Owns
Bayer CropScience Limited owed ₹0.48 for every ₹1 it owned in Mar 2026, up from ₹0.42 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.48× | 0.46× | 0.38× | 0.42× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Bayer CropScience Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 25.8%Receivables 19.6%Inventory 37.5%Fixed assets (tangible) 7.2%Intangible assets 2.7%Other assets 7.2%
How it's funded — Mar 2026
Short-term debt 0.8%Long-term debt 0.7%Payables 21.7%Other liabilities 24.8%Shareholders' equity 52.0%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,472.0 | 920.9 | 1,210.7 | 901.9 |
| Receivables | 1,115.5 | 952.1 | 960.1 | 975.6 |
| Inventory | 2,135.5 | 2,361.8 | 1,545.2 | 1,807.2 |
| Fixed assets (tangible) | 408.7 | 429.4 | 384.8 | 436.0 |
| Intangible assets | 155.3 | 136.4 | 125.4 | 114.7 |
| Long-term investments | 4.4 | 4.8 | 7.2 | 5.4 |
| Other assets | 408.0 | 440.5 | 363.7 | 437.8 |
| Liabilities & equity | ||||
| Short-term debt | 43.0 | 43.5 | 26.1 | 37.1 |
| Long-term debt | 38.8 | 61.6 | 21.0 | 36.4 |
| Payables | 1,237.9 | 1,098.4 | 605.1 | 873.2 |
| Other liabilities | 1,414.0 | 1,192.0 | 1,095.5 | 1,019.8 |
| Shareholders' equity | 2,965.7 | 2,850.4 | 2,849.4 | 2,712.1 |
| Net tangible assets | 2,810.4 | 2,714.0 | 2,724.0 | 2,597.4 |
Bayer CropScience Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 10,785,000,000.0 | 2,620,000,000.0 | 9,516,000,000.0 | 6,093,000,000.0 | — |
| Investing Activities | 725,000,000.0 | 856,000,000.0 | 4,000,000.0 | 833,000,000.0 | — |
| Financing Activities | -6,238,000,000.0 | -6,194,000,000.0 | -6,563,000,000.0 | -6,132,000,000.0 | — |